Steris (STE) Non-Current Deferred Tax Liability (2018 - 2026)
Steris (STE) posted Non-Current Deferred Tax Liability of $390.8 million for Q2 2026, little changed on a QoQ basis from $390.7 million in Q1 2026, and down 5.01% year-over-year from $411.4 million in Q2 2025.
Analysis
Steris (STE) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends
Steris has reported Non-Current Deferred Tax Liability for 9 years, with the latest figure at $390.8 million in Q2 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 5.01% year-over-year to $390.8 million in Q2 2026; TTM through Jun 2026 was $390.8 million, a 5.01% decrease from a year earlier, with the FY2026 full-year figure at $390.7 million, down 3.22% from the prior year.
- Non-Current Deferred Tax Liability was $390.8 million for Q2 2026 at Steris, roughly flat from $390.7 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $790.8 million in Q2 2022, with the low at $390.7 million in Q1 2026.
- Average Non-Current Deferred Tax Liability over 5 years is $541.7 million, with a median of $471.2 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Non-Current Deferred Tax Liability jumped 229.57% in 2022, then retreated 27.04% in 2024.
- Over 5 years, Non-Current Deferred Tax Liability stood at $724.6 million in 2022, then declined by 14.29% to $621.1 million in 2023, then declined by 27.04% to $453.1 million in 2024, then decreased by 8.52% to $414.5 million in 2025, then declined by 5.72% to $390.8 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $390.8 million (Q2 2026), $390.7 million (Q1 2026), and $414.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.79 Bn | 179.19 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.38 Bn | 119.16 Bn | 1.96 Bn |
| 3 | Medtronic | 118.45 Bn | 109.63 Bn | 6.34 Bn |
| 4 | Stryker | 105.32 Bn | 101.84 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.71 Bn | 66.17 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.81 Bn | 45.56 Bn | 1.35 Bn |
| 7 | Alcon | 34.03 Bn | 32.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.35 Bn | 30.40 Bn | 830.00 Mn |
| 9 | Steris | 21.17 Bn | 20.68 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 390.80 Mn |
| Mar 31, 2026 | 390.70 Mn |
| Dec 31, 2025 | 414.50 Mn |
| Sep 30, 2025 | 412.00 Mn |
| Jun 30, 2025 | 411.40 Mn |
| Mar 31, 2025 | 403.70 Mn |
| Dec 31, 2024 | 453.13 Mn |
| Sep 30, 2024 | 462.74 Mn |
| Jun 30, 2024 | 456.47 Mn |
| Mar 31, 2024 | 479.69 Mn |
| Dec 31, 2023 | 621.07 Mn |
| Sep 30, 2023 | 613.45 Mn |
| Jun 30, 2023 | 617.63 Mn |
| Mar 31, 2023 | 617.54 Mn |
| Dec 31, 2022 | 724.65 Mn |
| Sep 30, 2022 | 710.09 Mn |
| Jun 30, 2022 | 790.82 Mn |
| Mar 31, 2022 | 780.62 Mn |
| Dec 31, 2021 | 752.46 Mn |
| Sep 30, 2021 | 752.88 Mn |